GACM
ANIP icon

Global Alpha Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Global Alpha Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.2M Buy
558,003
+196,763
+54% +$15.8M 2.77% 12
2026
Q1 		$27.8M Sell
361,240
-228,895
-39% -$17.9M 1.67% 32
2025
Q4 		$46.6M Sell
590,135
-40,455
-6% -$3.5M 2.84% 9
2025
Q3 		$57.8M Sell
630,590
-231,500
-27% -$18.9M 3.3% 8
2025
Q2 		$56.3M Buy
862,090
+126,500
+17% +$8.24M 3.51% 8
2025
Q1 		$49.2M Buy
735,590
+111,040
+18% +$6.63M 3.58% 6
2024
Q4 		$34.5M Buy
624,550
+88,100
+16% +$5.06M 2.51% 16
2024
Q3 		$32M Buy
536,450
+9,500
+2% +$580K 2.08% 23
2024
Q2 		$33.6M Buy
526,950
+136,200
+35% +$8.84M 2.45% 16
2024
Q1 		$27M Sell
390,750
-191,678
-33% -$11.6M 2.01% 22
2023
Q4 		$32.1M Buy
582,428
+56,900
+11% +$3.13M 2.58% 14
2023
Q3 		$30.5M Buy
525,528
+72,200
+16% +$4.17M 3.06% 11
2023
Q2 		$24.4M Sell
453,328
-9,633
-2% -$427K 2.29% 22
2023
Q1 		$18.4M Buy
462,961
+13,430
+3% +$566K 1.67% 26
2022
Q4 		$18.1M Buy
449,531
+30,200
+7% +$1.13M 1.77% 25
2022
Q3 		$13.5M Buy
419,331
+95,600
+30% +$3.27M 1.35% 30
2022
Q2 		$9.61M Sell
323,731
-26,500
-8% -$764K 1.04% 32
2022
Q1 		$9.85M Buy
350,231
+65,400
+23% +$2.44M 0.85% 35
2021
Q4 		$13.1M Buy
284,831
+220,399
+342% +$9.47M 1.27% 31
2021
Q3 		$2.12M Buy
+64,432
New +$2M 0.23% 35
2020
Q4 		– Sell
-258,946
Closed -$7.3M – 37
2020
Q3 		$7.3M Sell
258,946
-16,300
-6% -$485K 1.12% 32
2020
Q2 		$8.9M Buy
275,246
+57,500
+26% +$2.06M 1.41% 29
2020
Q1 		$8.87M Buy
217,746
+48,000
+28% +$2.55M 1.6% 25
2019
Q4 		$10.5M Buy
169,746
+22,700
+15% +$1.5M 1.55% 27
2019
Q3 		$10.7M Buy
147,046
+4,600
+3% +$344K 1.86% 20
2019
Q2 		$11.7M Buy
142,446
+45,935
+48% +$3.27M 2.04% 21
2019
Q1 		$6.81M Buy
+96,511
New +$5.68M 1.3% 34

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Global Alpha Capital Management's ANIP Position: Q2 2026 in Review

Global Alpha Capital Management increased its ANI Pharmaceuticals (ANIP) stake by 54% in Q2 2026, buying an estimated $15.8M and bringing the position to 558,003 shares worth $46.2M. The position accounts for 2.77% of the portfolio, ranked #12.

Global Alpha Capital Management first reported a position in ANIP in Q1 2019 and has held it in 27 quarters since. The position peaked at $57.8M in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Global Alpha Capital Management held 558,003 shares of ANI Pharmaceuticals worth $46.2M as of Q2 2026.
  • Global Alpha Capital Management bought 196,763 ANI Pharmaceuticals shares in Q2 2026, an estimated $15.8M.
  • ANI Pharmaceuticals made up 2.77% of Global Alpha Capital Management's portfolio in Q2 2026, its #12 holding.
  • Global Alpha Capital Management first reported a position in ANI Pharmaceuticals in Q1 2019 and has held it in 27 quarters since.
  • Global Alpha Capital Management's ANI Pharmaceuticals position peaked at $57.8M in Q3 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Global Alpha Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.